nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—pancreatic cancer	0.574	0.774	CbGaD
Tolmetin—PTGS2—pancreatic cancer	0.167	0.226	CbGaD
Tolmetin—MPO—superior mesenteric artery—pancreatic cancer	0.0437	0.757	CbGeAlD
Tolmetin—CXCL8—islet of Langerhans—pancreatic cancer	0.00384	0.0665	CbGeAlD
Tolmetin—CXCL8—pancreas—pancreatic cancer	0.0027	0.0468	CbGeAlD
Tolmetin—MPO—pancreas—pancreatic cancer	0.00158	0.0273	CbGeAlD
Tolmetin—PTGS2—gall bladder—pancreatic cancer	0.00155	0.0269	CbGeAlD
Tolmetin—MPO—digestive system—pancreatic cancer	0.00135	0.0234	CbGeAlD
Tolmetin—PTGS2—islet of Langerhans—pancreatic cancer	0.00102	0.0176	CbGeAlD
Tolmetin—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.00101	0.00927	CcSEcCtD
Tolmetin—Proteinuria—Gemcitabine—pancreatic cancer	0.000993	0.00912	CcSEcCtD
Tolmetin—Protein urine present—Gemcitabine—pancreatic cancer	0.000979	0.00899	CcSEcCtD
Tolmetin—Visual disturbance—Tamoxifen—pancreatic cancer	0.000972	0.00893	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Erlotinib—pancreatic cancer	0.000911	0.00837	CcSEcCtD
Tolmetin—Cardiac failure congestive—Sunitinib—pancreatic cancer	0.00087	0.00799	CcSEcCtD
Tolmetin—Blood urea increased—Gemcitabine—pancreatic cancer	0.000823	0.00756	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.000821	0.00754	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—pancreatic cancer	0.000812	0.198	CrCbGaD
Tolmetin—Gastritis—Erlotinib—pancreatic cancer	0.000807	0.00741	CcSEcCtD
Tolmetin—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.000763	0.00701	CcSEcCtD
Tolmetin—Weight increased—Tamoxifen—pancreatic cancer	0.000725	0.00666	CcSEcCtD
Tolmetin—Weight decreased—Tamoxifen—pancreatic cancer	0.00072	0.00662	CcSEcCtD
Tolmetin—PTGS2—pancreas—pancreatic cancer	0.000715	0.0124	CbGeAlD
Tolmetin—Weight decreased—Erlotinib—pancreatic cancer	0.000713	0.00655	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00071	0.00653	CcSEcCtD
Tolmetin—Cardiac failure congestive—Gemcitabine—pancreatic cancer	0.000698	0.00641	CcSEcCtD
Tolmetin—Renal failure—Erlotinib—pancreatic cancer	0.00069	0.00634	CcSEcCtD
Tolmetin—Urinary tract infection—Tamoxifen—pancreatic cancer	0.00069	0.00634	CcSEcCtD
Tolmetin—Visual disturbance—Irinotecan—pancreatic cancer	0.000686	0.0063	CcSEcCtD
Tolmetin—Stomatitis—Erlotinib—pancreatic cancer	0.000685	0.00629	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.000671	0.00617	CcSEcCtD
Tolmetin—Epistaxis—Erlotinib—pancreatic cancer	0.000662	0.00609	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.000654	0.00601	CcSEcCtD
Tolmetin—Abdominal discomfort—Sunitinib—pancreatic cancer	0.000654	0.006	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.00065	0.00597	CcSEcCtD
Tolmetin—PTGS1—digestive system—pancreatic cancer	0.000639	0.0111	CbGeAlD
Tolmetin—Hepatitis—Tamoxifen—pancreatic cancer	0.000637	0.00585	CcSEcCtD
Tolmetin—Hepatitis—Erlotinib—pancreatic cancer	0.000631	0.00579	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.000622	0.00572	CcSEcCtD
Tolmetin—Blood pressure increased—Docetaxel—pancreatic cancer	0.000619	0.00569	CcSEcCtD
Tolmetin—Weight decreased—Sunitinib—pancreatic cancer	0.000617	0.00567	CcSEcCtD
Tolmetin—Visual impairment—Tamoxifen—pancreatic cancer	0.000614	0.00564	CcSEcCtD
Tolmetin—PTGS2—digestive system—pancreatic cancer	0.000611	0.0106	CbGeAlD
Tolmetin—Ketorolac—PTGS2—pancreatic cancer	0.000603	0.147	CrCbGaD
Tolmetin—Erythema multiforme—Tamoxifen—pancreatic cancer	0.000603	0.00553	CcSEcCtD
Tolmetin—Renal failure—Sunitinib—pancreatic cancer	0.000598	0.00549	CcSEcCtD
Tolmetin—Erythema multiforme—Erlotinib—pancreatic cancer	0.000596	0.00548	CcSEcCtD
Tolmetin—Stomatitis—Sunitinib—pancreatic cancer	0.000593	0.00544	CcSEcCtD
Tolmetin—Urinary tract infection—Sunitinib—pancreatic cancer	0.000591	0.00543	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—pancreatic cancer	0.000578	0.141	CrCbGaD
Tolmetin—Epistaxis—Sunitinib—pancreatic cancer	0.000573	0.00527	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00057	0.00524	CcSEcCtD
Tolmetin—Indomethacin—PPARG—pancreatic cancer	0.000561	0.137	CrCbGaD
Tolmetin—Hepatitis—Sunitinib—pancreatic cancer	0.000546	0.00501	CcSEcCtD
Tolmetin—Flatulence—Erlotinib—pancreatic cancer	0.000541	0.00497	CcSEcCtD
Tolmetin—Erythema multiforme—Sunitinib—pancreatic cancer	0.000516	0.00474	CcSEcCtD
Tolmetin—Weight decreased—Irinotecan—pancreatic cancer	0.000508	0.00467	CcSEcCtD
Tolmetin—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.000495	0.00455	CcSEcCtD
Tolmetin—Renal failure—Irinotecan—pancreatic cancer	0.000492	0.00452	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—pancreatic cancer	0.000491	0.12	CrCbGaD
Tolmetin—Stomatitis—Irinotecan—pancreatic cancer	0.000488	0.00448	CcSEcCtD
Tolmetin—Renal failure—Gemcitabine—pancreatic cancer	0.00048	0.00441	CcSEcCtD
Tolmetin—Stomatitis—Gemcitabine—pancreatic cancer	0.000476	0.00437	CcSEcCtD
Tolmetin—Visual disturbance—Docetaxel—pancreatic cancer	0.000474	0.00435	CcSEcCtD
Tolmetin—Chest pain—Tamoxifen—pancreatic cancer	0.000472	0.00434	CcSEcCtD
Tolmetin—Flatulence—Sunitinib—pancreatic cancer	0.000468	0.0043	CcSEcCtD
Tolmetin—Stomatitis—Fluorouracil—pancreatic cancer	0.000468	0.00429	CcSEcCtD
Tolmetin—Chest pain—Erlotinib—pancreatic cancer	0.000467	0.00429	CcSEcCtD
Tolmetin—Urinary tract infection—Fluorouracil—pancreatic cancer	0.000466	0.00428	CcSEcCtD
Tolmetin—Haematuria—Gemcitabine—pancreatic cancer	0.000465	0.00427	CcSEcCtD
Tolmetin—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000455	0.00418	CcSEcCtD
Tolmetin—Glossitis—Epirubicin—pancreatic cancer	0.000453	0.00416	CcSEcCtD
Tolmetin—Oedema—Tamoxifen—pancreatic cancer	0.000453	0.00416	CcSEcCtD
Tolmetin—Epistaxis—Fluorouracil—pancreatic cancer	0.000452	0.00416	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000449	0.00413	CcSEcCtD
Tolmetin—Oedema—Erlotinib—pancreatic cancer	0.000448	0.00411	CcSEcCtD
Tolmetin—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000448	0.00411	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—pancreatic cancer	0.000447	0.109	CrCbGaD
Tolmetin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000443	0.00407	CcSEcCtD
Tolmetin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000439	0.00403	CcSEcCtD
Tolmetin—Visual impairment—Irinotecan—pancreatic cancer	0.000433	0.00398	CcSEcCtD
Tolmetin—Glossitis—Doxorubicin—pancreatic cancer	0.000419	0.00385	CcSEcCtD
Tolmetin—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000414	0.0038	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000405	0.00372	CcSEcCtD
Tolmetin—Chest pain—Sunitinib—pancreatic cancer	0.000405	0.00372	CcSEcCtD
Tolmetin—Dyspepsia—Tamoxifen—pancreatic cancer	0.000399	0.00366	CcSEcCtD
Tolmetin—Dyspepsia—Erlotinib—pancreatic cancer	0.000394	0.00362	CcSEcCtD
Tolmetin—Blood urea increased—Epirubicin—pancreatic cancer	0.000394	0.00362	CcSEcCtD
Tolmetin—Oedema—Sunitinib—pancreatic cancer	0.000388	0.00356	CcSEcCtD
Tolmetin—Constipation—Tamoxifen—pancreatic cancer	0.000387	0.00356	CcSEcCtD
Tolmetin—Flatulence—Irinotecan—pancreatic cancer	0.000386	0.00354	CcSEcCtD
Tolmetin—Constipation—Erlotinib—pancreatic cancer	0.000383	0.00352	CcSEcCtD
Tolmetin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00038	0.00349	CcSEcCtD
Tolmetin—Suprofen—PTGS2—pancreatic cancer	0.000372	0.0908	CrCbGaD
Tolmetin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00037	0.0034	CcSEcCtD
Tolmetin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000366	0.00336	CcSEcCtD
Tolmetin—Blood urea increased—Doxorubicin—pancreatic cancer	0.000365	0.00335	CcSEcCtD
Tolmetin—Urticaria—Tamoxifen—pancreatic cancer	0.00036	0.0033	CcSEcCtD
Tolmetin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000358	0.00329	CcSEcCtD
Tolmetin—Lymphadenopathy—Epirubicin—pancreatic cancer	0.000355	0.00326	CcSEcCtD
Tolmetin—Abdominal pain—Erlotinib—pancreatic cancer	0.000354	0.00325	CcSEcCtD
Tolmetin—Body temperature increased—Erlotinib—pancreatic cancer	0.000354	0.00325	CcSEcCtD
Tolmetin—Weight increased—Docetaxel—pancreatic cancer	0.000353	0.00325	CcSEcCtD
Tolmetin—Weight decreased—Docetaxel—pancreatic cancer	0.000351	0.00323	CcSEcCtD
Tolmetin—Dyspepsia—Sunitinib—pancreatic cancer	0.000341	0.00314	CcSEcCtD
Tolmetin—Renal failure—Docetaxel—pancreatic cancer	0.00034	0.00313	CcSEcCtD
Tolmetin—Vascular purpura—Epirubicin—pancreatic cancer	0.000339	0.00311	CcSEcCtD
Tolmetin—Stomatitis—Docetaxel—pancreatic cancer	0.000337	0.0031	CcSEcCtD
Tolmetin—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000334	0.00307	CcSEcCtD
Tolmetin—Constipation—Sunitinib—pancreatic cancer	0.000332	0.00305	CcSEcCtD
Tolmetin—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000329	0.00302	CcSEcCtD
Tolmetin—Epistaxis—Docetaxel—pancreatic cancer	0.000327	0.003	CcSEcCtD
Tolmetin—Asthenia—Tamoxifen—pancreatic cancer	0.000325	0.00298	CcSEcCtD
Tolmetin—Chest pain—Gemcitabine—pancreatic cancer	0.000325	0.00298	CcSEcCtD
Tolmetin—Agranulocytosis—Docetaxel—pancreatic cancer	0.000323	0.00297	CcSEcCtD
Tolmetin—Asthenia—Erlotinib—pancreatic cancer	0.000321	0.00295	CcSEcCtD
Tolmetin—Oedema—Irinotecan—pancreatic cancer	0.000319	0.00293	CcSEcCtD
Tolmetin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000319	0.00293	CcSEcCtD
Tolmetin—Chest pain—Fluorouracil—pancreatic cancer	0.000319	0.00293	CcSEcCtD
Tolmetin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000317	0.00291	CcSEcCtD
Tolmetin—Purpura—Epirubicin—pancreatic cancer	0.000314	0.00289	CcSEcCtD
Tolmetin—Vascular purpura—Doxorubicin—pancreatic cancer	0.000313	0.00288	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000313	0.00288	CcSEcCtD
Tolmetin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000313	0.00287	CcSEcCtD
Tolmetin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000311	0.00286	CcSEcCtD
Tolmetin—Oedema—Gemcitabine—pancreatic cancer	0.000311	0.00286	CcSEcCtD
Tolmetin—Hepatitis—Docetaxel—pancreatic cancer	0.000311	0.00285	CcSEcCtD
Tolmetin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00031	0.00285	CcSEcCtD
Tolmetin—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000309	0.00284	CcSEcCtD
Tolmetin—Abdominal pain—Sunitinib—pancreatic cancer	0.000307	0.00282	CcSEcCtD
Tolmetin—Body temperature increased—Sunitinib—pancreatic cancer	0.000307	0.00282	CcSEcCtD
Tolmetin—Diarrhoea—Erlotinib—pancreatic cancer	0.000306	0.00282	CcSEcCtD
Tolmetin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000306	0.00281	CcSEcCtD
Tolmetin—Oedema—Fluorouracil—pancreatic cancer	0.000306	0.00281	CcSEcCtD
Tolmetin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000305	0.0028	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000303	0.00278	CcSEcCtD
Tolmetin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.0003	0.00275	CcSEcCtD
Tolmetin—Visual impairment—Docetaxel—pancreatic cancer	0.0003	0.00275	CcSEcCtD
Tolmetin—Dizziness—Tamoxifen—pancreatic cancer	0.000299	0.00275	CcSEcCtD
Tolmetin—Dizziness—Erlotinib—pancreatic cancer	0.000296	0.00272	CcSEcCtD
Tolmetin—Erythema multiforme—Docetaxel—pancreatic cancer	0.000294	0.0027	CcSEcCtD
Tolmetin—Purpura—Doxorubicin—pancreatic cancer	0.000291	0.00267	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00029	0.00266	CcSEcCtD
Tolmetin—Vomiting—Tamoxifen—pancreatic cancer	0.000288	0.00264	CcSEcCtD
Tolmetin—Vomiting—Erlotinib—pancreatic cancer	0.000285	0.00262	CcSEcCtD
Tolmetin—Somnolence—Irinotecan—pancreatic cancer	0.000284	0.00261	CcSEcCtD
Tolmetin—Headache—Tamoxifen—pancreatic cancer	0.000284	0.00261	CcSEcCtD
Tolmetin—Dyspepsia—Irinotecan—pancreatic cancer	0.000281	0.00258	CcSEcCtD
Tolmetin—Headache—Erlotinib—pancreatic cancer	0.000281	0.00258	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.00028	0.00258	CcSEcCtD
Tolmetin—Asthenia—Sunitinib—pancreatic cancer	0.000278	0.00256	CcSEcCtD
Tolmetin—Somnolence—Gemcitabine—pancreatic cancer	0.000277	0.00254	CcSEcCtD
Tolmetin—Constipation—Irinotecan—pancreatic cancer	0.000273	0.00251	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000273	0.00251	CcSEcCtD
Tolmetin—Somnolence—Fluorouracil—pancreatic cancer	0.000272	0.0025	CcSEcCtD
Tolmetin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000269	0.00247	CcSEcCtD
Tolmetin—Nausea—Tamoxifen—pancreatic cancer	0.000269	0.00247	CcSEcCtD
Tolmetin—Gastritis—Epirubicin—pancreatic cancer	0.000268	0.00246	CcSEcCtD
Tolmetin—Constipation—Gemcitabine—pancreatic cancer	0.000266	0.00244	CcSEcCtD
Tolmetin—Nausea—Erlotinib—pancreatic cancer	0.000266	0.00244	CcSEcCtD
Tolmetin—Diarrhoea—Sunitinib—pancreatic cancer	0.000265	0.00244	CcSEcCtD
Tolmetin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000261	0.0024	CcSEcCtD
Tolmetin—Dizziness—Sunitinib—pancreatic cancer	0.000256	0.00236	CcSEcCtD
Tolmetin—Body temperature increased—Irinotecan—pancreatic cancer	0.000253	0.00232	CcSEcCtD
Tolmetin—Abdominal pain—Irinotecan—pancreatic cancer	0.000253	0.00232	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000252	0.00232	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—pancreatic cancer	0.000248	0.00228	CcSEcCtD
Tolmetin—Vomiting—Sunitinib—pancreatic cancer	0.000247	0.00226	CcSEcCtD
Tolmetin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000246	0.00226	CcSEcCtD
Tolmetin—Dysuria—Epirubicin—pancreatic cancer	0.000245	0.00225	CcSEcCtD
Tolmetin—Urticaria—Fluorouracil—pancreatic cancer	0.000243	0.00223	CcSEcCtD
Tolmetin—Headache—Sunitinib—pancreatic cancer	0.000243	0.00223	CcSEcCtD
Tolmetin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000242	0.00222	CcSEcCtD
Tolmetin—Weight increased—Epirubicin—pancreatic cancer	0.000238	0.00219	CcSEcCtD
Tolmetin—Weight decreased—Epirubicin—pancreatic cancer	0.000237	0.00218	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—pancreatic cancer	0.000237	0.0577	CrCbGaD
Tolmetin—Drowsiness—Epirubicin—pancreatic cancer	0.000234	0.00215	CcSEcCtD
Tolmetin—Chest pain—Docetaxel—pancreatic cancer	0.00023	0.00212	CcSEcCtD
Tolmetin—Nausea—Sunitinib—pancreatic cancer	0.00023	0.00212	CcSEcCtD
Tolmetin—Renal failure—Epirubicin—pancreatic cancer	0.00023	0.00211	CcSEcCtD
Tolmetin—Asthenia—Irinotecan—pancreatic cancer	0.000229	0.00211	CcSEcCtD
Tolmetin—Stomatitis—Epirubicin—pancreatic cancer	0.000228	0.00209	CcSEcCtD
Tolmetin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000227	0.00209	CcSEcCtD
Tolmetin—Dysuria—Doxorubicin—pancreatic cancer	0.000227	0.00208	CcSEcCtD
Tolmetin—Asthenia—Gemcitabine—pancreatic cancer	0.000223	0.00205	CcSEcCtD
Tolmetin—Haematuria—Epirubicin—pancreatic cancer	0.000223	0.00205	CcSEcCtD
Tolmetin—Oedema—Docetaxel—pancreatic cancer	0.000221	0.00203	CcSEcCtD
Tolmetin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000221	0.00203	CcSEcCtD
Tolmetin—Weight increased—Doxorubicin—pancreatic cancer	0.000221	0.00203	CcSEcCtD
Tolmetin—Epistaxis—Epirubicin—pancreatic cancer	0.00022	0.00202	CcSEcCtD
Tolmetin—Weight decreased—Doxorubicin—pancreatic cancer	0.000219	0.00201	CcSEcCtD
Tolmetin—Diarrhoea—Irinotecan—pancreatic cancer	0.000219	0.00201	CcSEcCtD
Tolmetin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000218	0.002	CcSEcCtD
Tolmetin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000216	0.00199	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—pancreatic cancer	0.000216	0.00198	CcSEcCtD
Tolmetin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000213	0.00196	CcSEcCtD
Tolmetin—Renal failure—Doxorubicin—pancreatic cancer	0.000212	0.00195	CcSEcCtD
Tolmetin—Dizziness—Irinotecan—pancreatic cancer	0.000211	0.00194	CcSEcCtD
Tolmetin—Stomatitis—Doxorubicin—pancreatic cancer	0.000211	0.00193	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00021	0.00193	CcSEcCtD
Tolmetin—Hepatitis—Epirubicin—pancreatic cancer	0.00021	0.00193	CcSEcCtD
Tolmetin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000209	0.00192	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—pancreatic cancer	0.000206	0.00189	CcSEcCtD
Tolmetin—Epistaxis—Doxorubicin—pancreatic cancer	0.000204	0.00187	CcSEcCtD
Tolmetin—Vomiting—Irinotecan—pancreatic cancer	0.000203	0.00187	CcSEcCtD
Tolmetin—Dizziness—Fluorouracil—pancreatic cancer	0.000202	0.00186	CcSEcCtD
Tolmetin—Visual impairment—Epirubicin—pancreatic cancer	0.000202	0.00186	CcSEcCtD
Tolmetin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000202	0.00185	CcSEcCtD
Tolmetin—Headache—Irinotecan—pancreatic cancer	0.0002	0.00184	CcSEcCtD
Tolmetin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000198	0.00182	CcSEcCtD
Tolmetin—Vomiting—Gemcitabine—pancreatic cancer	0.000198	0.00182	CcSEcCtD
Tolmetin—Somnolence—Docetaxel—pancreatic cancer	0.000196	0.0018	CcSEcCtD
Tolmetin—Tinnitus—Epirubicin—pancreatic cancer	0.000195	0.0018	CcSEcCtD
Tolmetin—Headache—Gemcitabine—pancreatic cancer	0.000195	0.00179	CcSEcCtD
Tolmetin—Vomiting—Fluorouracil—pancreatic cancer	0.000195	0.00179	CcSEcCtD
Tolmetin—Dyspepsia—Docetaxel—pancreatic cancer	0.000194	0.00179	CcSEcCtD
Tolmetin—Hepatitis—Doxorubicin—pancreatic cancer	0.000194	0.00178	CcSEcCtD
Tolmetin—Headache—Fluorouracil—pancreatic cancer	0.000192	0.00176	CcSEcCtD
Tolmetin—Nausea—Irinotecan—pancreatic cancer	0.00019	0.00174	CcSEcCtD
Tolmetin—Constipation—Docetaxel—pancreatic cancer	0.000189	0.00173	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—pancreatic cancer	0.000187	0.00172	CcSEcCtD
Tolmetin—Nausea—Gemcitabine—pancreatic cancer	0.000185	0.0017	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000183	0.00168	CcSEcCtD
Tolmetin—Nausea—Fluorouracil—pancreatic cancer	0.000182	0.00167	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—pancreatic cancer	0.000181	0.00166	CcSEcCtD
Tolmetin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000181	0.00166	CcSEcCtD
Tolmetin—Flatulence—Epirubicin—pancreatic cancer	0.00018	0.00165	CcSEcCtD
Tolmetin—Abdominal pain—Docetaxel—pancreatic cancer	0.000175	0.0016	CcSEcCtD
Tolmetin—Body temperature increased—Docetaxel—pancreatic cancer	0.000175	0.0016	CcSEcCtD
Tolmetin—Flatulence—Doxorubicin—pancreatic cancer	0.000166	0.00153	CcSEcCtD
Tolmetin—Asthenia—Docetaxel—pancreatic cancer	0.000158	0.00146	CcSEcCtD
Tolmetin—Chest pain—Epirubicin—pancreatic cancer	0.000155	0.00143	CcSEcCtD
Tolmetin—Diarrhoea—Docetaxel—pancreatic cancer	0.000151	0.00139	CcSEcCtD
Tolmetin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000149	0.00137	CcSEcCtD
Tolmetin—Oedema—Epirubicin—pancreatic cancer	0.000149	0.00137	CcSEcCtD
Tolmetin—Dizziness—Docetaxel—pancreatic cancer	0.000146	0.00134	CcSEcCtD
Tolmetin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000146	0.00134	CcSEcCtD
Tolmetin—Chest pain—Doxorubicin—pancreatic cancer	0.000144	0.00132	CcSEcCtD
Tolmetin—Vomiting—Docetaxel—pancreatic cancer	0.00014	0.00129	CcSEcCtD
Tolmetin—Headache—Docetaxel—pancreatic cancer	0.000138	0.00127	CcSEcCtD
Tolmetin—Oedema—Doxorubicin—pancreatic cancer	0.000138	0.00127	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000138	0.00127	CcSEcCtD
Tolmetin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000135	0.00124	CcSEcCtD
Tolmetin—Somnolence—Epirubicin—pancreatic cancer	0.000132	0.00122	CcSEcCtD
Tolmetin—Nausea—Docetaxel—pancreatic cancer	0.000131	0.0012	CcSEcCtD
Tolmetin—Dyspepsia—Epirubicin—pancreatic cancer	0.000131	0.0012	CcSEcCtD
Tolmetin—Constipation—Epirubicin—pancreatic cancer	0.000127	0.00117	CcSEcCtD
Tolmetin—Somnolence—Doxorubicin—pancreatic cancer	0.000123	0.00113	CcSEcCtD
Tolmetin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000122	0.00112	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000121	0.00111	CcSEcCtD
Tolmetin—Urticaria—Epirubicin—pancreatic cancer	0.000118	0.00109	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—pancreatic cancer	0.000118	0.00108	CcSEcCtD
Tolmetin—Abdominal pain—Epirubicin—pancreatic cancer	0.000118	0.00108	CcSEcCtD
Tolmetin—Body temperature increased—Epirubicin—pancreatic cancer	0.000118	0.00108	CcSEcCtD
Tolmetin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000113	0.00104	CcSEcCtD
Tolmetin—Urticaria—Doxorubicin—pancreatic cancer	0.000109	0.00101	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000109	0.001	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000109	0.001	CcSEcCtD
Tolmetin—Asthenia—Epirubicin—pancreatic cancer	0.000107	0.000982	CcSEcCtD
Tolmetin—Diarrhoea—Epirubicin—pancreatic cancer	0.000102	0.000936	CcSEcCtD
Tolmetin—Asthenia—Doxorubicin—pancreatic cancer	9.89e-05	0.000908	CcSEcCtD
Tolmetin—Dizziness—Epirubicin—pancreatic cancer	9.85e-05	0.000905	CcSEcCtD
Tolmetin—Vomiting—Epirubicin—pancreatic cancer	9.47e-05	0.00087	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—pancreatic cancer	9.43e-05	0.000866	CcSEcCtD
Tolmetin—Headache—Epirubicin—pancreatic cancer	9.33e-05	0.000857	CcSEcCtD
Tolmetin—Dizziness—Doxorubicin—pancreatic cancer	9.11e-05	0.000837	CcSEcCtD
Tolmetin—Nausea—Epirubicin—pancreatic cancer	8.85e-05	0.000813	CcSEcCtD
Tolmetin—Vomiting—Doxorubicin—pancreatic cancer	8.76e-05	0.000805	CcSEcCtD
Tolmetin—Headache—Doxorubicin—pancreatic cancer	8.63e-05	0.000793	CcSEcCtD
Tolmetin—Nausea—Doxorubicin—pancreatic cancer	8.19e-05	0.000752	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—pancreatic cancer	7.97e-05	0.000906	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRLHR—pancreatic cancer	7.93e-05	0.000902	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCK—pancreatic cancer	7.92e-05	0.0009	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatic cancer	7.91e-05	0.000899	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TYMS—pancreatic cancer	7.84e-05	0.000891	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CNR2—pancreatic cancer	7.71e-05	0.000877	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GLP1R—pancreatic cancer	7.71e-05	0.000877	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—pancreatic cancer	7.6e-05	0.000864	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCKAR—pancreatic cancer	7.59e-05	0.000863	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	7.57e-05	0.00086	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—pancreatic cancer	7.56e-05	0.000859	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IAPP—pancreatic cancer	7.53e-05	0.000855	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ZNRF3—pancreatic cancer	7.46e-05	0.000848	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ACVR1B—pancreatic cancer	7.46e-05	0.000848	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.41e-05	0.000842	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—GCG—pancreatic cancer	7.33e-05	0.000833	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	7.33e-05	0.000833	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—STAT3—pancreatic cancer	7.29e-05	0.000829	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—pancreatic cancer	7.27e-05	0.000826	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—pancreatic cancer	7.26e-05	0.000825	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PTHLH—pancreatic cancer	7.22e-05	0.000821	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	7.2e-05	0.000818	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—RB1—pancreatic cancer	7.17e-05	0.000815	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	7.13e-05	0.00081	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—pancreatic cancer	6.99e-05	0.000795	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—SHH—pancreatic cancer	6.92e-05	0.000786	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IAPP—pancreatic cancer	6.83e-05	0.000777	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DTX1—pancreatic cancer	6.75e-05	0.000767	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SSTR3—pancreatic cancer	6.75e-05	0.000767	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—SST—pancreatic cancer	6.61e-05	0.000751	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTCH1—pancreatic cancer	6.56e-05	0.000745	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTHLH—pancreatic cancer	6.56e-05	0.000745	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SSTR1—pancreatic cancer	6.47e-05	0.000735	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—APOE—pancreatic cancer	6.38e-05	0.000725	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PPY—pancreatic cancer	6.34e-05	0.000721	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—pancreatic cancer	6.34e-05	0.00072	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SSTR2—pancreatic cancer	6.23e-05	0.000708	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CNR1—pancreatic cancer	6.1e-05	0.000693	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	6.02e-05	0.000684	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCKBR—pancreatic cancer	6.01e-05	0.000683	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—SST—pancreatic cancer	6e-05	0.000682	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—pancreatic cancer	5.93e-05	0.000674	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GCG—pancreatic cancer	5.89e-05	0.000669	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CG—pancreatic cancer	5.76e-05	0.000654	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	5.72e-05	0.00065	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GLI1—pancreatic cancer	5.65e-05	0.000643	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DTX4—pancreatic cancer	5.65e-05	0.000643	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AGTR1—pancreatic cancer	5.62e-05	0.000638	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	5.61e-05	0.000637	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—pancreatic cancer	5.57e-05	0.000633	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—pancreatic cancer	5.57e-05	0.000633	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PPARG—pancreatic cancer	5.56e-05	0.000631	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CNR1—pancreatic cancer	5.54e-05	0.000629	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—pancreatic cancer	5.51e-05	0.000626	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PPP2R5B—pancreatic cancer	5.5e-05	0.000625	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRP1—pancreatic cancer	5.5e-05	0.000625	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	5.47e-05	0.000622	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.45e-05	0.00062	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GCG—pancreatic cancer	5.35e-05	0.000608	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	5.33e-05	0.000605	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HEY2—pancreatic cancer	5.29e-05	0.000602	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	5.22e-05	0.000593	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	5.18e-05	0.000589	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	5.17e-05	0.000588	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GAST—pancreatic cancer	5.17e-05	0.000588	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AGTR1—pancreatic cancer	5.1e-05	0.00058	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CD—pancreatic cancer	5.06e-05	0.000575	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	5.03e-05	0.000572	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PRSS1—pancreatic cancer	4.92e-05	0.00056	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SCT—pancreatic cancer	4.9e-05	0.000557	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HEY1—pancreatic cancer	4.9e-05	0.000557	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCK—pancreatic cancer	4.68e-05	0.000531	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRSS1—pancreatic cancer	4.67e-05	0.00053	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ZNRF3—pancreatic cancer	4.67e-05	0.00053	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CNR2—pancreatic cancer	4.56e-05	0.000518	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GLP1R—pancreatic cancer	4.56e-05	0.000518	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCKAR—pancreatic cancer	4.48e-05	0.00051	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CB—pancreatic cancer	4.41e-05	0.000501	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	4.4e-05	0.000501	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—pancreatic cancer	4.37e-05	0.000497	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAG2—pancreatic cancer	4.35e-05	0.000494	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MEN1—pancreatic cancer	4.28e-05	0.000487	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	4.27e-05	0.000486	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ARG2—pancreatic cancer	4.27e-05	0.000485	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	4.26e-05	0.000484	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DTX1—pancreatic cancer	4.22e-05	0.00048	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—pancreatic cancer	4.21e-05	0.000478	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	4.18e-05	0.000475	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SHH—pancreatic cancer	4.09e-05	0.000465	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH4—pancreatic cancer	4.06e-05	0.000462	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IAPP—pancreatic cancer	4.04e-05	0.000459	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	3.98e-05	0.000452	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PRSS1—pancreatic cancer	3.91e-05	0.000444	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTCH1—pancreatic cancer	3.88e-05	0.00044	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTHLH—pancreatic cancer	3.88e-05	0.00044	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—pancreatic cancer	3.86e-05	0.000438	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTEN—pancreatic cancer	3.81e-05	0.000433	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMP—pancreatic cancer	3.73e-05	0.000424	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.72e-05	0.000423	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.62e-05	0.000412	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.59e-05	0.000408	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SST—pancreatic cancer	3.54e-05	0.000403	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DTX4—pancreatic cancer	3.54e-05	0.000402	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	3.51e-05	0.000399	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.5e-05	0.000397	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.5e-05	0.000397	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAG1—pancreatic cancer	3.47e-05	0.000394	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH3—pancreatic cancer	3.45e-05	0.000393	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PPP2R5B—pancreatic cancer	3.44e-05	0.000391	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ARG2—pancreatic cancer	3.39e-05	0.000385	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HEY2—pancreatic cancer	3.31e-05	0.000376	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CNR1—pancreatic cancer	3.27e-05	0.000372	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.24e-05	0.000369	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CG—pancreatic cancer	3.17e-05	0.000361	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.16e-05	0.000359	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GCG—pancreatic cancer	3.16e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.08e-05	0.00035	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.07e-05	0.000349	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HEY1—pancreatic cancer	3.07e-05	0.000348	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGTR1—pancreatic cancer	3.01e-05	0.000342	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GLP1R—pancreatic cancer	3.01e-05	0.000342	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STK11—pancreatic cancer	2.97e-05	0.000338	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMP—pancreatic cancer	2.96e-05	0.000337	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DPYD—pancreatic cancer	2.96e-05	0.000336	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—pancreatic cancer	2.96e-05	0.000336	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.91e-05	0.00033	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.9e-05	0.00033	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.84e-05	0.000323	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC2A2—pancreatic cancer	2.81e-05	0.000319	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CD—pancreatic cancer	2.79e-05	0.000317	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.78e-05	0.000316	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAG2—pancreatic cancer	2.72e-05	0.000309	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.71e-05	0.000308	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—pancreatic cancer	2.69e-05	0.000306	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.69e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.68e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MEN1—pancreatic cancer	2.68e-05	0.000305	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.68e-05	0.000304	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC2A2—pancreatic cancer	2.66e-05	0.000302	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMAD4—pancreatic cancer	2.6e-05	0.000296	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SHH—pancreatic cancer	2.56e-05	0.000291	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HES1—pancreatic cancer	2.54e-05	0.000289	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IAPP—pancreatic cancer	2.53e-05	0.000287	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.47e-05	0.00028	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.44e-05	0.000278	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.44e-05	0.000278	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CB—pancreatic cancer	2.43e-05	0.000276	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HSPA1B—pancreatic cancer	2.42e-05	0.000275	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GLP1R—pancreatic cancer	2.39e-05	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.39e-05	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—DPYD—pancreatic cancer	2.35e-05	0.000267	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC2A2—pancreatic cancer	2.23e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TERT—pancreatic cancer	2.23e-05	0.000253	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.21e-05	0.000251	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—pancreatic cancer	2.2e-05	0.00025	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD44—pancreatic cancer	2.17e-05	0.000247	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAG1—pancreatic cancer	2.17e-05	0.000247	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.13e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.13e-05	0.000242	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIF1A—pancreatic cancer	2.13e-05	0.000242	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TSC2—pancreatic cancer	2.12e-05	0.000241	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.11e-05	0.00024	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GCG—pancreatic cancer	2.08e-05	0.000237	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOE—pancreatic cancer	2.08e-05	0.000236	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD44—pancreatic cancer	2.06e-05	0.000234	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HSPA1A—pancreatic cancer	2.05e-05	0.000233	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KDR—pancreatic cancer	2.04e-05	0.000231	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.02e-05	0.000229	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—STK11—pancreatic cancer	1.96e-05	0.000223	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.94e-05	0.00022	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NFKBIA—pancreatic cancer	1.94e-05	0.00022	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH1—pancreatic cancer	1.92e-05	0.000218	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—pancreatic cancer	1.88e-05	0.000213	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NRAS—pancreatic cancer	1.88e-05	0.000213	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGF—pancreatic cancer	1.85e-05	0.000211	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.84e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD44—pancreatic cancer	1.73e-05	0.000196	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—pancreatic cancer	1.71e-05	0.000194	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.69e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMS—pancreatic cancer	1.69e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GCG—pancreatic cancer	1.65e-05	0.000188	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CD—pancreatic cancer	1.65e-05	0.000187	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.63e-05	0.000186	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMAD4—pancreatic cancer	1.63e-05	0.000185	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—pancreatic cancer	1.61e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HES1—pancreatic cancer	1.59e-05	0.000181	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—STK11—pancreatic cancer	1.56e-05	0.000177	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—pancreatic cancer	1.48e-05	0.000169	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.46e-05	0.000166	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CB—pancreatic cancer	1.44e-05	0.000163	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TERT—pancreatic cancer	1.39e-05	0.000158	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—pancreatic cancer	1.37e-05	0.000156	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOE—pancreatic cancer	1.37e-05	0.000156	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMS—pancreatic cancer	1.34e-05	0.000152	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—pancreatic cancer	1.33e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIF1A—pancreatic cancer	1.33e-05	0.000151	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TSC2—pancreatic cancer	1.33e-05	0.000151	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—pancreatic cancer	1.32e-05	0.00015	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOE—pancreatic cancer	1.3e-05	0.000148	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.3e-05	0.000148	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—pancreatic cancer	1.29e-05	0.000146	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—pancreatic cancer	1.27e-05	0.000145	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—pancreatic cancer	1.25e-05	0.000142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—pancreatic cancer	1.24e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—pancreatic cancer	1.24e-05	0.000141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—pancreatic cancer	1.21e-05	0.000138	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOTCH1—pancreatic cancer	1.2e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—pancreatic cancer	1.19e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGF—pancreatic cancer	1.16e-05	0.000132	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SRC—pancreatic cancer	1.15e-05	0.000131	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—pancreatic cancer	1.12e-05	0.000127	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—pancreatic cancer	1.11e-05	0.000126	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRAS—pancreatic cancer	1.11e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOE—pancreatic cancer	1.09e-05	0.000124	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.09e-05	0.000124	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—pancreatic cancer	1.03e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CD—pancreatic cancer	1.03e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.03e-05	0.000117	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—pancreatic cancer	1.03e-05	0.000117	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—pancreatic cancer	1.01e-05	0.000115	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—pancreatic cancer	9.82e-06	0.000112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—pancreatic cancer	9.53e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CB—pancreatic cancer	9.48e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—pancreatic cancer	9.48e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—pancreatic cancer	9.4e-06	0.000107	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CB—pancreatic cancer	8.99e-06	0.000102	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—pancreatic cancer	8.76e-06	9.95e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CD—pancreatic cancer	8.64e-06	9.81e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—pancreatic cancer	8.47e-06	9.63e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—pancreatic cancer	8.19e-06	9.31e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—pancreatic cancer	8.1e-06	9.21e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—pancreatic cancer	7.97e-06	9.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—pancreatic cancer	7.77e-06	8.83e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CB—pancreatic cancer	7.53e-06	8.55e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SRC—pancreatic cancer	7.2e-06	8.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—pancreatic cancer	7.16e-06	8.13e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—pancreatic cancer	6.95e-06	7.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NRAS—pancreatic cancer	6.93e-06	7.87e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—pancreatic cancer	6.5e-06	7.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—pancreatic cancer	6.45e-06	7.34e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—pancreatic cancer	6.44e-06	7.32e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—pancreatic cancer	6.31e-06	7.17e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—pancreatic cancer	5.96e-06	6.78e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—pancreatic cancer	5.78e-06	6.57e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—pancreatic cancer	5.48e-06	6.23e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—pancreatic cancer	5.07e-06	5.76e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—pancreatic cancer	4.72e-06	5.37e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—pancreatic cancer	4.59e-06	5.21e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—pancreatic cancer	4.48e-06	5.09e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—pancreatic cancer	3.75e-06	4.26e-05	CbGpPWpGaD
